Search
 
Skip Navigation Links
Skip Navigation Links
Skip Navigation Links
Over Active Bladder –Quality of Life Implications
OAB is a clinical syndrome defined as urgency with or without urge incontinence usually with frequency and nocturia. It is a common problem: one... Read More
 
Over Active Bladder –Quality of Life Implications
Introduction
OAB is a clinical syndrome charectarized by urgency, frequency, nocturia and incontinence usually.  This syndrome affects  greatly the quality of life.
Body

OAB is a clinical syndrome defined as urgency with or without urge incontinence usually with frequency and nocturia. It is a common problem: one European survey of 16776 people aged 40 or older found an overall prevalence of over active bladder symptoms were frequency (85 per cent), urgency (54 per cent) and urge incontinence (36 per cent).

The overall prevalence of OAB is similar in men and women but incontinence is more common and symptoms worsen sooner among women. prevalence increases differently with age from 9 per cent in women and 3 per cent in men aged 40-44, 31 and 42 per cent respectively at age 75 or older.

OAB adversely affects quality of life in about 30 per cent of people aged 40 or older in UK, with a significant impact on social and physical functioning, emotion and particularly mobility in women. There is also a significant detrimental effect on mood and quality of sleep .Urinary urgency is the symptom patients say is most troubling, with the greater impact on quality of life than incontinence, frequency or nocturia.

Overall the impact of OAB on quality of life reported by patients is comparable with that associated with diabetes.

Concordance issues in OAB
Despite the associated morbidity many patients do not take their medication as prescribed or discontinue treatment. In one randomized trial involving 348 patients with OAB (defined as detrusor instability), of the 256 who could be followed up, only 18 percent has persisted with anticholinergic drug treatment for at least 6 months
Three analyses of US medical claims databases found that few patient persist with treatment for a year ,even with newer modified – release formulations that are claimed to reduce adverse effects.

In one, 47 per cent of patients taken an anticholinergic drug had stopped treatment after 3 months and 82 per cent had stopped by the year's end ; the mean duration of treatment was 86 days.
The second analysis found that 88 per cent of patients stopped treatment within a year , mostly within 6 months and only 15 per cent of patient took at least 80 per cent of their prescribed medication .
In the third, the mean duration of treatment for first time users of anticholinergic drugs was 91 days with oxybutynin and 143 days with tolterodine.

Theses studies did not investigate the reasons for this early discontinuation of treatment but it is likely that lack of effectiveness and adverse effects are the most common causes.

Adherence to treatment could be improved by adopting a joint approach between patient and healthcare provider. To achieve this ,clinicians need to enquire about patients' beliefs and concerns about their condition and its treatment and give them autonomy in decision making .in turn, patients need to understand their condition and the options for treatment they should have realistic expectations of what can be achieved with drug treatment and of the nature and likely hood of adverse effects so they can agree suitable goals and they should be offered ongoing support .

Finally, treatment should deliver an improvement in symptoms without the penalty of intolerable adverse effects .

Adapted from wagg, A; Maffatt, J.; and spinks, J.eds.confidence through bladder control .the role of propverine – current thinking
1- Abrams p, cardozo L, fall M,et al.the standardization of terminology of lower urinary tract function : report from the standardization sub committee of the international continence society . neurourol urodynamics 2002;21:167-78

2- milsom 1 , Abrams P,cardozo L, et al . How widespread are the symptoms of an overactive bladder and how are they managed? A population- based prevalence study. BJU int 2001; 87:760-6.

3- Mcgrother CW, Donaldson MM,shaw C,etal storage symptoms of the bladder : prevalence incidence and need for services in the UK.BJU Int 2004;93:763-9.

4- Strew WF,van rooyen JB,cundiff Gw,etal prevalence and burden of overactive bladder in the united states world J urol  2003;20:327-36.

5- van der vaart CH , De Leeuw JR , Roovers JP, et al. the effect of urinary incontinence and over active bladder symptoms on quality of life in young women.BJU Int 2002;90:544-9.

6- coyne KS, Zhou Z thomptoms c.versi E.the impact of urinary urgency and frequency on health-related quality of life in overactive bladder : results from a national community survey.value health 2004;7:455-63.

7- Kelleher CJ,Cardozo LD, Khuller V,et al a medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compiliance. Br J Obstel Gynaecol 1997;104:988-93.

8- Mcghan wf.cost effectiveness and quality of life considerations in the treatment of patients with overactive bladder .Am J manage care 2001;7:62-75

9- Noe L, sneeringer R, patel B, et al .the implications of poor meducation persistence with treatment for overactive bladder.manag care interface 2004:17:54-60.

10- Chui MA,Williamson T,Arciniegra J et al .patient persistency with medications for overactive bladder .value health 2004;7:366(abstract).

11-YU YF, Yu AP , Ahn J, et al. Medication treatment persistence of overactive bladder /urinary incontinence patients in a California Medicaid program and the benefit of their refill adherence on urinary tract infection .value health 2003;6:191.

12-Zhou Z, Barr C, Torigoe Y, et al. persistence of therapy with drugs for overactive bladder value health 2001;4:161(abstract)

13- Dowell J.Jones A, Snadden D .exploring medication use to seek concordance with non adherent' patients: a qualitative study. Brj Gen pract 2002;52:24-32.

 
Light and sound therapy may boost brain function
New evidence suggests that a combined light and sound stimulation therapy could boost brain health and improve the symptoms of Alzheimer's disease.
Alzheimer's disease: An eye test could provide early warning
One day, a quick eye test may be able to pick up important information about brain health. Specifically, it may be able to identify signs of dementia.
Does eating mushrooms protect brain health?
Mushrooms are tasty and nutritious, but can they protect the brain from cognitive decline? That is what researchers from Singapore aim to find out.
Vascular risk factors tied to brain health
New research finds that risk factors affecting the health of our blood vessels — such as smoking, obesity, or diabetes — may also impair brain health.
Could sleep apnea be a risk factor for Alzheimer's?
A preliminary study has unearthed a potential link between sleep apnea and tau tangles, which are the neurological hallmarks of Alzheimer's disease.
This sleep disorder puts people at 'very high risk' of Parkinson's
A large study found that those who experience a certain sleep disorder are also at high risk of Parkinson's disease, but this knowledge can aid prevention.
How does exercise impact cognitive function in Parkinson's?
A recent systematic review suggests that exercise improves not only motor function in people with Parkinson's disease, but also their memory.
Excessive daily TV at older age tied to poorer memory
Adults aged 50 and older who watched TV for 3.5 hours or more per day had greater verbal memory decline after 6 years than those who watched less TV.
ALS: New technique prevents toxic protein deposits in cells
Clumps of faulty TDP-43 protein inside nerve cells are common in ALS and other neurological diseases. Could this new technique offer a way to prevent them?
Alzheimer's: 'Holy herb' extract shows promise as future treatment
A laboratory screen found that a compound in the Yerba santa medicinal plant protects against several age-related triggers of death in mouse nerve cells.
How language shapes our brains...and our lives
In this Spotlight, we look at the origins of spoken language, where language is present in the brain, and how the languages we speak shape our world.
The unexpected dangers of gum disease
According to recent research, gum disease may increase the risk of a range of seemingly unrelated conditions, including cancer and dementia.
What are the early signs of dementia?
There are 10 early signs and symptoms of dementia, including misplacing things, difficulty solving problems, and confusing times and places. Learn about the other signs in this article.
Diabetes and Alzheimer's: What's the link?
Although scientists have linked Alzheimer's and diabetes, the exact connection has been difficult to unpick. A recent study now gives further insight.
Study finds new cognitive decline mechanism in Alzheimer's
A new animal study has identified the cellular mechanism that leads to reduced blood flow to the brain, which, in turn, impacts cognitive function.
Inflammation in midlife hastens cognitive decline
Understanding the risk factors of cognitive decline are now more important than ever. A recent study examined the potential role of inflammation.
Alzheimer's: How do tau tangles grow?
Researchers use a mathematical model and lab experiments to unravel the process through which tangles of the protein tau grow in length.
Blood-clotting protein contributes to Alzheimer's
Though experts typically name beta-amyloid plaques as the main culprits in Alzheimer's disease, new research finds another factor: a leaked blood protein.
Does education really protect against dementia?
Does the length of time an individual spends in education reduce the risk of developing dementia? A new, large-scale study investigates.
Dementia: Could gut bacteria play a role?
A new study links changes in gut bacteria to dementia. The researchers hope that their findings might, one day, help develop more effective treatment.
Dementia: The worrying 'rise of pseudomedicine'
In a recent article, a team of neurologists attacks an ongoing increase in pseudomedicine that claims to protect brain health and treat dementia.
Hearing loss and cognitive decline: Study probes link
Data from an 8-year study of 10,000 men aged 62 or older reveals a link between hearing loss and a markedly greater risk of subjective cognitive decline.
Mild cognitive impairment: Reducing blood pressure can lower risk
Controlling systolic blood pressure to below 120 mm Hg significantly lowered the risk of mild cognitive impairment in older adults.
How gum disease could lead to Alzheimer's
Researchers find that an oral bacterium usually linked to gum disease also plays a role in Alzheimer's. This finding has led to a new therapeutic approach.
Even low-level activity may help reduce dementia risk
According to a recent study, older adults who move around more are likely to have significantly better memory and thinking skills.
<March 2019>
SatSunMonTueWedThuFri
2324252627281
2345678
9101112131415
16171819202122
23242526272829
303112345
Home | Partners | Products | Researches| Monthly Articles | Distribution| Marketing | Useful Links | Careers | Contact Us | Site Map
Site Developed By Netegypt © 2010 TCHERO. All Rights Reserved.